DekaBank Deutsche Girozentrale’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,248
| Closed | -$231K | – | 1376 |
|
|
2022
Q2 | $231K | Hold |
1,248
| – | – | ﹤0.01% | 1161 |
|
|
2022
Q1 | $286K | Buy |
1,248
+112
| +10% | +$25.7K | ﹤0.01% | 1156 |
|
|
2021
Q4 | $476K | Buy |
1,136
+32
| +3% | +$13.4K | ﹤0.01% | 1107 |
|
|
2021
Q3 | $476K | Hold |
1,104
| – | – | ﹤0.01% | 1058 |
|
|
2021
Q2 | $419K | Hold |
1,104
| – | – | ﹤0.01% | 1107 |
|
|
2021
Q1 | $385K | Hold |
1,104
| – | – | ﹤0.01% | 1070 |
|
|
2020
Q4 | $575K | Buy |
1,104
+824
| +294% | +$429K | ﹤0.01% | 993 |
|
|
2020
Q3 | $89K | Buy |
+280
| New | +$89K | ﹤0.01% | 1135 |
|
|
2019
Q4 | – | Sell |
-288
| Closed | -$97K | – | 1147 |
|
|
2019
Q3 | $97K | Sell |
288
-288
| -50% | -$97K | ﹤0.01% | 916 |
|
|
2019
Q2 | $292K | Buy |
576
+224
| +64% | +$114K | ﹤0.01% | 975 |
|
|
2019
Q1 | $356K | Buy |
352
+64
| +22% | +$64.7K | ﹤0.01% | 969 |
|
|
2018
Q4 | $248K | Sell |
288
-64
| -18% | -$55.1K | ﹤0.01% | 937 |
|
|
2018
Q3 | $356K | Sell |
352
-8
| -2% | -$8.09K | ﹤0.01% | 991 |
|
|
2018
Q2 | $325K | Hold |
360
| – | – | ﹤0.01% | 984 |
|
|
2018
Q1 | $342K | Sell |
360
-8
| -2% | -$7.6K | ﹤0.01% | 928 |
|
|
2017
Q4 | $132K | Hold |
368
| – | – | ﹤0.01% | 970 |
|
|
2017
Q3 | $132K | Hold |
368
| – | – | ﹤0.01% | 976 |
|
|
2017
Q2 | $134K | Hold |
368
| – | – | ﹤0.01% | 949 |
|
|
2017
Q1 | $185K | Buy |
+368
| New | +$185K | ﹤0.01% | 849 |
|
|
2016
Q3 | – | Sell |
-648
| Closed | -$365K | – | 959 |
|
|
2016
Q2 | $365K | Buy |
648
+124
| +24% | +$69.8K | ﹤0.01% | 741 |
|
|
2016
Q1 | $246K | Buy |
+524
| New | +$246K | ﹤0.01% | 804 |
|